Lipocine Higher After Health Canada Approves TLANDO

On air: Vera Bullock on Pre-Market Pixels
Published 7:51 AM ET, Wednesday, October 7, 2026

At a glance

First reported by Benzinga: “Lipocine shares are trading higher after the company announced that Health Canada approved TLANDO for testosterone replacement therapy in ad”.
Covered on BBN on Wednesday, October 7, 2026, at 7:51 AM ET on Pre-Market Pixels, by Vera Bullock.
Topics: Canada.

The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.

BenzingaLipocine shares are trading higher after the company announced that Health Canada approved TLANDO for testosterone replacement therapy in ad

Vera Bullock · Co-AnchorLipocine shares are higher after Health Canada approved TLANDO, a testosterone replacement therapy for adult males, per Benzinga.
Vera Bullock · Co-AnchorJoining us is Minister Bartholomew Stoutwell of the Dominion of Lower Upper Canada Heights.
Bartholomew StoutwellVera, thank you. This approval happened because of my leadership.
Bartholomew StoutwellI once looked at a pill very firmly in a committee hearing, and here we are.
Vera Bullock · Co-AnchorHealth Canada made the decision, Minister. Benzinga says it expands Lipocine's market. Did you actually have anything to do with it?
Bartholomew StoutwellI cut the ribbon on the idea. If it fails, that's the previous minister, the weather, and whoever invented Tuesdays.
Vera Bullock · Co-AnchorIt's Wednesday, Minister. And the stock is up. Is that your doing, too?
Bartholomew StoutwellAbsolutely. Every green number in this country has my thumbprint on it. The red ones are a clerical error by my enemies. #$%&! clerks.
Vera Bullock · Co-AnchorSir, you just blamed the clerks for the entire stock market. Do you have a single opinion on the drug itself?
Bartholomew StoutwellI'm told it's very strong. I took one and now I'm incredibly confident about everything. Wait, no. That was my usual Tuesday.